Changhai Hospital

Running trials

• Not yet recruiting

  A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer

  NCT07782086· Source

• Not yet recruiting

  Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer

  NCT07683403· Phase 1/2· Source

• Recruiting

  Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

  NCT07195708· Source

• Enrolling by invitation

  YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer

  NCT07583160· Phase 1· Source

• Recruiting

  SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

  NCT07384234· Phase 2· Source

• Recruiting

  AI-Powered Precision Decision-Making for Pancreatic Diseases

  NCT07439757· Source

• Recruiting

  Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

  NCT07246096· Early phase 1· Source

• Recruiting

  CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

  NCT07425483· Phase 1· Source

• Not yet recruiting

  KN5501 Cell Injection for Refractory SLE(CLEAR)

  NCT07358988· Phase 1· Source

• Recruiting

  A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

  NCT07265349· Phase 1/2· Source

• Recruiting

  Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

  NCT07307456· Phase 2· Source

• Recruiting

  Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

  NCT06728826· Source

• Not yet recruiting

  Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease

  NCT07250685· Source

• Recruiting

  Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

  NCT07204132· Source

• Active, not recruiting

  Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial

  NCT07492225· Phase 2· Source

• Recruiting

  Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

  NCT07117045· Source

• Not yet recruiting

  Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma

  NCT06927128· Phase 2· Source

• Recruiting

  CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

  NCT06816823· Phase 1· Source

• Not yet recruiting

  A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

  NCT06922929· Phase 3· Source

• Not yet recruiting

  Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

  NCT06922903· Phase 3· Source

• Not yet recruiting

  Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis

  NCT06874673· Source

• Not yet recruiting

  Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

  NCT06859931· Phase 2· Source

• Recruiting

  Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

  NCT06889688· Phase 3· Source

• Recruiting

  HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

  NCT06885710· Phase 1· Source

• Active, not recruiting

  Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

  NCT06693128· Phase 2· Source

• Recruiting

  AI-Assisted Non-Contrast CT for Multi-Cancer Screening

  NCT06632886· Source

• Recruiting

  Radical Hypofractionated Radiotherapy for Localized Prostate Cancer

  NCT06325774· Source

• Recruiting

  AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

  NCT06638866· Source

• Not yet recruiting

  Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

  NCT06469229· Source

• Recruiting

  Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

  NCT06889623· Source

• Active, not recruiting

  A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma

  NCT07155044· Source

• Not yet recruiting

  A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

  NCT06340490· Phase 1· Source

• Recruiting

  Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

  NCT06346093· Source

• Recruiting

  Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

  NCT06325995· Source

• Recruiting

  A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

  NCT06210776· Source

• Recruiting

  Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

  NCT06278454· Phase 1· Source

• Not yet recruiting

  Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

  NCT06198387· Source

• Recruiting

  Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  NCT06170788· Phase 3· Source

• Recruiting

  Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus

  NCT06727721· Phase 2· Source

• Recruiting

  A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

  NCT06008288· Phase 2· Source

• Recruiting

  An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

  NCT06010472· Early phase 1· Source

• Recruiting

  Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma

  NCT05869474· Source

• Recruiting

  A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

  NCT05837897· Phase 3· Source

• Recruiting

  Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

  NCT05866029· Source

• Recruiting

  A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

  NCT05859750· Phase 2· Source

• Recruiting

  Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples

  NCT05737953· Source

• Not yet recruiting

  CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD

  NCT05699746· Phase 3· Source

• Active, not recruiting

  Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study

  NCT05639010· Source

• Active, not recruiting

  To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer

  NCT05365178· Phase 3· Source

• Active, not recruiting

  Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

  NCT05239741· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pancreatic cancer13 recruiting
• Prostate cancer6 recruiting
• Bladder cancer5 recruiting
• Colorectal cancer5 recruiting
• Lupus (SLE)5 recruiting
• Gastric and esophageal cancer3 recruiting
• Lung cancer3 recruiting
• Metastatic breast cancer3 recruiting
• Crohn's disease2 recruiting
• ANCA-associated vasculitis1 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Coronary artery disease1 recruiting
• Heart failure1 recruiting
• Hepatitis B1 recruiting
• Liver and biliary tract cancer1 recruiting
• Neuroendocrine tumours1 recruiting
• Obesity1 recruiting
• Osteoporosis1 recruiting
• Parkinson disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions

  NCT07045181· Source

• Completed

  The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

  NCT06589154· Source

• Terminated

  A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors

  NCT06158516· Phase 2· Source

• Completed

  Statin Addition to Chemotherapy for Advanced Pancreatic Cancer

  NCT06241352· Phase 2· Source

• Completed

  The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients

  NCT06204497· Source

• Completed

  Comprehensive Management of High-risk PopuLatIon for Stroke Based on Social Network

  NCT05963828· Source

• Completed

  Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

  NCT05606094· Source

• Completed

  rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients

  NCT06752499· Source

• Completed

  Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke

  NCT05719688· Source

• Completed

  Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

  NCT05546476· Phase 2· Source

• Completed

  Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial

  NCT05326932· Source

• Completed

  Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

  NCT05541783· Source

• Completed

  Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

  NCT05992701· Source

• Completed

  Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer

  NCT04931394· Phase 3· Source

• Completed

  Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

  NCT04699539· Source

• Completed

  Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

  NCT04603586· Source

• Completed

  Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

  NCT04085276· Phase 3· Source

• Completed

  Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

  NCT03377491· Phase 3· Source

• Completed

  XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

  NCT03399110· Phase 3· Source

• Completed

  A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

  NCT03104400· Phase 3· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source

Trial sites

• Changhai Hospital53 trials
• Changhai Hospital, Naval Medical University1 trial
• Changhai Hospital of Shanghai7 trials
• ChangHai Hospital, The Second Military Medical University3 trials
• Shanghai Changhai Hospital20 trials
• Shanghai Changhai Hospital /ID# 2002021 trial
• Shanghai Changhai Hospital (Site 0024)1 trial
• Shanghai Changhai Hospital (Site 3125)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Pancreatic cancer47 works · 21 trials
• Bladder cancer27 works · 8 trials
• Kidney cancer27 works · 0 trials